Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Buy GenoLogics

NEW YORK (GenomeWeb) – Illumina has signed an agreement to acquire GenoLogics Life Sciences Software, a developer of laboratory information management systems for life science organizations, for an undisclosed amount.

The acquisition is expected to close by the end of August. Following the close of purchase, GenoLogics will become part of Illumina's enterprise informatics business and will be under the purview of Sanjay Chikarmane, senior vice president and general manager of enterprise informatics.

The company developed and sells the GenoLogics' Clarity LIMS software, a LIM system tailored for the needs of clinical and research laboratories. Clarity LIMS, which is optimized for use with Illumina sequencing instruments, offers improved sample throughput, increased accuracy, and fast turnaround, among other benefits, according to GenoLogics.

Illumina President Francis deSouza said in a statement that the acquisition demonstrates his firm's "commitment to drive the adoption of sequencing in new markets and improve the genomic information workflow."

"Adding GenoLogics' products to Illumina's portfolio is another example of our continued commitment to bring innovative sample-to-answer solutions to research and clinical labs," he said.

"Illumina and GenoLogics have had a longstanding partnership," Michael Ball, GenoLogics' CEO, added, "and this acquisition will enable us to widen our distribution, accelerate our product development, and provide even greater support to the Clarity LIMS community."